We are live on ! Find out more
BKYI

BIO-key International

8 hedge funds and large institutions have $761K invested in BIO-key International in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.04%0.03% (-0.01%)

33% less funds holding

Funds holding: 128 (-4)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

39% less capital invested

Capital invested by funds: $1.24M → $761K (-$478K)

49% less call options, than puts

Call options by funds: $51K | Put options by funds: $100K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
3
Closed
4
Calls
$51K
Puts
$100K
Net Calls
-$49K
Net Calls Change
+$508K

BKYI Hedge Fund Activity: Q2 2022 in Review

8 of the 5,957 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2022, worth a combined $761K — down 39% from $1.24M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BKYI and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Simplex Trading, adding an estimated $33K. The largest seller was Sabby Management, exiting entirely with an estimated $105K sold.

  • 8 institutional investors held BIO-key International (BKYI) as of Q2 2022, down from 12 in Q1 2022.
  • Funds reported $761K of BIO-key International stock for Q2 2022, down 39% quarter-over-quarter.
  • 0 funds opened new BIO-key International positions in Q2 2022 and 4 closed out, a net change of -4 holders.
  • The largest BIO-key International buyer in Q2 2022 was Simplex Trading, an estimated $33K added.
  • The largest BIO-key International seller in Q2 2022 was Sabby Management, an estimated $105K sold.

Based on aggregated 13F filings for Q2 2022.